| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 02/23/2006 | US20060040956 Substituted alkylamine derivatives and methods of use |
| 02/23/2006 | US20060040942 Antiinflammatory agents; autoimmune disease |
| 02/23/2006 | US20060040941 7-Aminoimidazotriazones |
| 02/23/2006 | US20060040933 Antiinflammatory agents |
| 02/23/2006 | US20060040876 Modulation of peroxisome proliferator-activated receptors |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040312 Uses of kappa-conotoxin PVIIA |
| 02/23/2006 | US20060040266 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2) |
| 02/23/2006 | US20060039959 Film-Shaped Mucoadhesive Administration Forms For Administering Cannabis Agents |
| 02/23/2006 | US20060039868 For use in therapy of chronic obstructive pulmonary disease and asthma; an inhalette capsule contains a mixture of coarser and fine excipient particles |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004038886A1 Pharmaceutical formulation useful for treating inflammatory and obstructive respiratory diseases comprises at least one anticholinergic compound, at least one corticosteroid and at least one betamimetic |
| 02/23/2006 | DE102004038885A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 02/23/2006 | CA2577274A1 Anti-inflammatory agents |
| 02/23/2006 | CA2577165A1 Oral killed vaccines and method for providing same |
| 02/23/2006 | CA2575385A1 Aerosol formulation for inhalation, containing an anticholinergenic agent |
| 02/23/2006 | CA2573761A1 Use of estrogen related receptor-modulating aryl ethers |
| 02/23/2006 | CA2573370A1 Inhalable medicaments containing corticosteroids, betamimetic and an anticholinergenic |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627880A1 Boronic ester and acid compounds, synthesis and uses |
| 02/22/2006 | EP1627873A1 Benzofuran compound and medicinal composition containing the same |
| 02/22/2006 | EP1627869A1 Amide derivative |
| 02/22/2006 | EP1627633A1 Oral pharmaceutical forms of administration with a delayed action with tramadol |
| 02/22/2006 | EP1626957A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 02/22/2006 | EP1626736A1 C1 inhibitor with short half-life for transient treatment |
| 02/22/2006 | EP1456210B1 Pyrazolyl-substituted triazoloquinoxalines |
| 02/22/2006 | EP1414812B1 Hydroxamic acid derivatives |
| 02/22/2006 | EP1385839B1 3-substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
| 02/22/2006 | EP1237874B1 Selective neurokinin antagonists |
| 02/22/2006 | EP1224187B1 Certain alkylene diamine-substituted heterocycles |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |
| 02/22/2006 | CN1738788A Substituted phenyl naphthalenes as estrogenic agents |
| 02/22/2006 | CN1738625A Benzo (1,2,5) thiadiazole ALS CRF-antagonisten |
| 02/22/2006 | CN1736479A Prevention, treatment and detection of pig progressive atrophic rhinitis |
| 02/22/2006 | CN1736474A Reversible heat gelling aquatic pharmaceutical composition of a Chinese medicine and compound prescription thereof |
| 02/22/2006 | CN1736450A Mint oil adding method in production of Chinese medicine 'pinellia dew tablet' |
| 02/22/2006 | CN1736443A Chinese medicinal ointment for treating pneumonia |
| 02/22/2006 | CN1736442A Asthma treating cigarette which can also be used as drug substitute |
| 02/22/2006 | CN1736435A Chinese medicinal preparation for treating rhinitis and preparation process thereof |
| 02/22/2006 | CN1736434A Throat comforting medicine with licorice and preparation process thereof |
| 02/22/2006 | CN1736424A Chinese medicinal preparation for treating throat disease and preparation process thereof |
| 02/22/2006 | CN1736418A Compound drop pills with licorice and its preparation method |
| 02/22/2006 | CN1736417A Composition for treating upper respiratory tract infection and application |
| 02/22/2006 | CN1736415A Effervescence tablet of 'Shuang Huanglian' and its preparation process thereof |
| 02/22/2006 | CN1736381A Use of morpholine methyltetralone in preparation of smooth muscles spasmolytic |
| 02/22/2006 | CN1736379A Moxifloxaci gelatin capsule and preparation process thereof |
| 02/22/2006 | CN1242992C Cyclic diamine compounds bearing six-membered cyclic groups |
| 02/22/2006 | CN1242810C Drug composition, its preparation method and use |
| 02/22/2006 | CN1242808C Chinese medicine for treating pulmonary heart disease |
| 02/22/2006 | CN1242798C Externally used Chinese traditional medicine for relieving cough |
| 02/22/2006 | CN1242796C Compound couth-relieving aster medicine and its preparation process |
| 02/22/2006 | CN1242783C Medicine for treating acute pharyngitis and acute tonsillitis and its preparing method |
| 02/22/2006 | CN1242770C Pharmaceutical compositions for treating wind-heat cough and its preparation process |
| 02/22/2006 | CN1242763C Method for preparing cough-stopping drop pills |
| 02/22/2006 | CN1242762C Chinese medicine compound spraying agent for treating acute, chronic nasitis and its preparation method |
| 02/22/2006 | CN1242754C Chinese traditional medicine for upper respiratory tract infection |
| 02/22/2006 | CN1242744C Nasal cavity preparation for treating long-term allergic reaction coryza |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7001917 2-(4-(4-(4-Fluorophenyl)-3,5-imethyl-1H-pyrazol-1-yl)phenyl) ethyl (4-methylphenyl)sulfonylcarbamate ammonium salt, e.g., as an antagonist for Prostoglandin E receptor; analgesics; antipyretics; antiinflammatory agents |
| 02/21/2006 | US7001914 Compounds |
| 02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/17/2006 | CA2478138A1 Cxcl10-based diagnosis and treatment of respiratory illnesses |
| 02/16/2006 | WO2006017505A2 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006016245A1 Muscarinic receptor antagonists |
| 02/16/2006 | WO2006015775A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035959 e.g. (dibenzofuran-4-yl)-(3,5-dichlorophenylamino)acetic acid; glycine B antagonist on the NMDA receptor complex for regulating the calcium balance; analgesic,antiinflammatory, antidepressant, anxiolytic agent, neurodegenerative diseases; chronic and neuropathic pain |
| 02/16/2006 | US20060035918 Use of tacrolimus (fk506) derivatives combined with beta2-agonists for the treatment of asthma |
| 02/16/2006 | US20060035916 2,4-Pyrimidinediamine compounds and their uses |
| 02/16/2006 | US20060035874 Pharmaceutical products and composition comprising specific anticholinergic agents, beta-2 agonists and corticosteroids |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035814 Reagents and methods for smooth muscle therapies |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060034928 Tablet comprising cetirizine and pseudoephedrine |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2575932A1 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| 02/16/2006 | CA2575588A1 Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic |
| 02/16/2006 | CA2575541A1 New pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| 02/15/2006 | EP1626049A1 Microcrystal |
| 02/15/2006 | EP1626048A1 Crystal of benzimidazole derivative and process for producing the same |
| 02/15/2006 | EP1625143A1 Estratriene derivatives |
| 02/15/2006 | EP1625127A1 Azaindole compounds as kinase inhibitors |
| 02/15/2006 | EP1625126A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors |
| 02/15/2006 | EP1624877A2 Use of steroid derivatives for the treatment of angiotensin ii related diseases e.g. cardiovascular and proliferative disorders |
| 02/15/2006 | EP1624866A2 Treatment of respiratory disease by inhalation of synthetic matrix metalloprotease inhibitors |
| 02/15/2006 | EP1624850A2 Compositions and methods for treatment of severe acute respiratory syndrome (sars) |
| 02/15/2006 | EP1487456B1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735615A Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 02/15/2006 | CN1735434A Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers |
| 02/15/2006 | CN1735415A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 02/15/2006 | CN1735414A Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists |
| 02/15/2006 | CN1733922A Super antigen fusion protein and its application method |